{{Rsnum
|rsid=6026990
|Gene=PHACTR3
|Chromosome=20
|position=59602560
|Orientation=plus
|GMAF=0.2121
|Gene_s=PHACTR3
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;T)
| geno3=(T;T)
| CEU | 0.0 | 6.3 | 93.7
| HCB | 4.4 | 51.1 | 44.4
| JPT | 11.4 | 40.9 | 47.7
| YRI | 11.3 | 37.1 | 51.6
| ASW | 0.0 | 0.0 | 0.0
| CHB | 4.4 | 51.1 | 44.4
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=22491018
|Trait=None
|Title=Genome-wide association analysis implicates the involvement of eight loci with response to tocilizumab for the treatment of rheumatoid arthritis.
|RiskAllele=
|Pval=6E-7
|OR=0.6300
|ORtxt=None
}}

{{on chip | HumanOmni1Quad}}